EVEROLIMUS

EVEROLIMUS (11591C)

everolimus 2 mg dispersible tablet, 30
11591C
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Refractory seizures associated with tuberous sclerosis complex
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $368.48 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Afinitor

EVEROLIMUS (11607X)

everolimus 2 mg dispersible tablet, 30
11607X
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17539)

Indication: Refractory seizures associated with tuberous sclerosis complex
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $368.48 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Afinitor